Neuro-Innovators collaborates with Spaulding Rehabilitation Hospital to evaluate NIV-001 therapy, targeting stroke patients' mobility and function restoration post-stroke.
The FDA-approved three-drug combination by Neuro-Innovators is designed to enhance neuroplasticity and healing after trauma, aiming for fast-track commercialization for stroke recovery.
[
add
]
[
|
|
...
]